Valley Forge Investment Consultants’s DataMeds AI MEDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-460
Closed -$2.22K 90
2026
Q1
$2.22K Hold
460
﹤0.01% 83
2025
Q4
$9.18K Hold
460
﹤0.01% 80
2025
Q3
$20.4K Hold
460
0.01% 84
2025
Q2
$22.3K Hold
460
0.01% 89
2025
Q1
$99.3K Buy
+460
New +$77.6K 0.04% 75

Other funds holding MEDS

Valley Forge Investment Consultants's MEDS Position: Q2 2026 in Review

Valley Forge Investment Consultants sold out of DataMeds AI (MEDS) in Q2 2026, closing a stake of 460 shares — an estimated $2.22K sold.

Valley Forge Investment Consultants first reported a position in MEDS in Q1 2025 and held it in 5 quarters. The position peaked at $99.3K in Q1 2025. 9 funds tracked by Wall St. Rank hold MEDS as of Q2 2026.

  • Valley Forge Investment Consultants reported no remaining DataMeds AI position as of Q2 2026 after selling out during the quarter.
  • Valley Forge Investment Consultants sold 460 DataMeds AI shares in Q2 2026, an estimated $2.22K.
  • Valley Forge Investment Consultants first reported a position in DataMeds AI in Q1 2025 and held it in 5 quarters.
  • Valley Forge Investment Consultants's DataMeds AI position peaked at $99.3K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held DataMeds AI as of Q2 2026.

Based on Valley Forge Investment Consultants's 13F filing for Q2 2026, filed 7 Aug 2026.